Skip to main content

Table 2 Nine AS events associated with the OS of patients with CESC

From: Comprehensive analysis of prognostic alternative splicing signature in cervical cancer

AS events

Coefficient

HR

HR.95L

HR.95H

P value

C1QTNF1-43985-AP

1.7165

5.564908

0.591273

52.37548

0.133464

OPA3-50486-AP

− 16.0778

1.04E-07

2.11E-10

5.13E-05

3.72E-07

CLIP1-24953-AD

− 24.6113

2.05E-11

2.02E-17

2.08E-05

0.000487

HNRNPA1-301521-ES

4.6100

100.4831

0.777403

12,987.93

0.063104

PRR13-22038-AA

− 9.3599

8.61E-05

1.42E-09

5.232286

0.095813

NDUFA3-51782-ES

5.0443

155.1364

9.500676

2533.221

0.0004

SERPING1-15865-AP

2.1513

8.595978

1.75865

42.01565

0.007877

RPS15A-34266-AD

8.1402

3,429.715

9.790151

1,201,508

0.006466

MAN2A2-32517-AA

− 2.9594

0.051851

0.005065

0.530781

0.012642

  1. AS alternative splicing, OS overall survival, CESC cervical squamous cell carcinoma and endocervical adenocarcinoma, HR hazard ratios